Primary Malignant Melanoma of the Parotid Gland: rimary Malignant Melanoma of the Parotid Gland: An Unusual Primary Site

Volume: 4 Number: 1 January 1, 2018
  • Melek Karakurt Eryılmaz
  • Hasan Mutlu
  • Fatma Yalçın Müsri
  • Derya Kıvrak Salim
  • Betül Ünal
  • Gülsüm Özlem Elpek
  • Hasan Şenol Çoskun
TR EN

Primary Malignant Melanoma of the Parotid Gland: rimary Malignant Melanoma of the Parotid Gland: An Unusual Primary Site

Abstract

Malignant melanoma MM of the parotid gland arising at such an unusual location is an exceptional and rare case only occasionally mentioned in the literature. Due to the different treatments and prognosis, a distinction between primary parotid gland MM and metastasis of MM is crucial.We report on a 57-year-old woman who presented with right parotid swelling.She underwent right total parotidectomy. Immunohistochemically, the tumor cells were positive staining for S-100, HMB-45, and Melan A. Since no other focus was detected, the patient was diagnosed with primary malignant melanoma of the parotid gland. Although malignant melanoma of the parotid gland is a rare diagnosis, clinicians should be aware of this presentation in the differential diagnosis of parotid tumors

Keywords

References

  1. 1. Kim HS, Kim EK, Jun HJ, Oh SY, Park KW, Lim do H, Lee SI, Kim JH, Kim KM, Lee DH, Lee J. Noncutaneous malignant melanoma: A prognostic model from a retrospective multicenter study. BMC Cancer 2010;10:167.
  2. 2. Guy GP Jr, Thomas CC, Thompson T, Watson M, Massetti GM, Richardson LC; Centers for Disease Control and Prevention (CDC). Vital signs: Melanoma incidence and mortality trends and projections - United States, 1982-2030. MMWR Morb Mortal Wkly Rep 2015;64(21):591-6.
  3. 3. Robert C, Karaszewska B, Schachter J, Rutkowski P, Mackiewicz A, Stroiakovski D, Lichinitser M, Dummer R, Grange F, Mortier L, Chiarion-Sileni V, Drucis K, Krajsova I, Hauschild A, Lorigan P, Wolter P, Long GV, Flaherty K, Nathan P, Ribas A, Martin AM, Sun P, Crist W, Legos J, Rubin SD, Little SM, Schadendorf D. Improved overall survival in melanoma with combined dabrafenib and trametinib. N Engl J Med 2015;372(1): 30-9.
  4. 4. Wilkins DK, Nathan PD. Therapeutic opportunities in noncutaneous melanoma. Ther Adv Med Oncol 2009;1(1): 29-36.
  5. 5. Hughes T, Klairmont M, Sharfman WH, Kaufman HL. Interleukin-2, Ipilimumab, and Anti-PD-1: Clinical management and the evolving role of immunotherapy for the treatment of patients with metastatic melanoma. Cancer Biol Ther 2015:0.
  6. 6. DePeralta DK, Boland GM. Melanoma: Advances in targeted therapy and molecular markers. Ann Surg Oncol 2015;22(11):3451-8.
  7. 7. Maier H, Mühlmeier G, Kraft K, Blumstein NM, Tisch M Primary malignant melanoma of the parotid gland: a case report and review of the literature. HNO 2008;56(6):627- 32. (In German).
  8. 8. Takeda Y. Melanocytes in the human parotid gland. Pathol Int 1997;47(8): 581-3.

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Melek Karakurt Eryılmaz This is me

Hasan Mutlu This is me

Fatma Yalçın Müsri This is me

Derya Kıvrak Salim This is me

Betül Ünal This is me

Gülsüm Özlem Elpek This is me

Hasan Şenol Çoskun This is me

Publication Date

January 1, 2018

Submission Date

-

Acceptance Date

-

Published in Issue

Year 2018 Volume: 4 Number: 1

Vancouver
1.Melek Karakurt Eryılmaz, Hasan Mutlu, Fatma Yalçın Müsri, Derya Kıvrak Salim, Betül Ünal, Gülsüm Özlem Elpek, Hasan Şenol Çoskun. Primary Malignant Melanoma of the Parotid Gland: rimary Malignant Melanoma of the Parotid Gland: An Unusual Primary Site. Akd Med J [Internet]. 2018 Jan. 1;4(1):63-6. Available from: https://izlik.org/JA64TT33UU